Spanish Decision Tool for Ovarian Cancer Maintenance Therapy

Study population: This study will enroll patients and clinical providers. Who May Qualify: Patients • Eligible patients must be: 1) individuals ≥ 18 years with advanced stage high grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are receiving or have completed platinum-based chemotherapy for ovarian cancer and are potentially eligible to receive maintenance therapy; 2) able to understand, speak or read in Spanish. Who Should NOT Join This Trial: Patients • Inability or unwillingness to sign willing to sign a consent form Who May Qualify: Clinicians • Eligible clinicians will include: 1) MD Anderson gynecologic oncologists and advanced practice providers who practice at the Houston Area Locations (HALs), MD Anderson Cancer Center, or our county safety net hospital, The Harris Health System (LBJ Hospital). Who Should NOT Join This Trial: Clinicians • Inability or unwillingness to sign willing to sign a consent form Always talk to your doctor about whether this trial is right for you.